Notably, the tumor cell-restricted cytotoxicity of TCRαβ+CD8αα+ IELs was significantly attenuated by the loss of Kdm6b, thus resulting in defective immune surveillance in Kdm6b-deficient mice. The gene discussed is KDM6B; the disease is neoplasm.